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INTRODUCTION: THE BODY, ECONOMIC POWER AND
SOCIAL CONTROL
DOROTHY NELKIN AND LORI B. ANDREWS*
A pregnant woman with a bar code on her belly demonstrates
against the commercialization of human cord blood., A patient sues
his physician for patenting a cell line made from his biopsied tissue.2
Two U.S. Marines are court martialed when they refuse to obey an
order to give DNA to an Armed Forces physician in case it was later
needed to identify their remains.' The U.S. Centers for Disease
Control have been challenged in a dispute over whether geneticists
can have access, without consent, to 50,000 stored tissue samples they
wish to use for their research., The body is a site of growing struggles.
The collection and use of human body tissue-from eighteenth
century practices of dissection to twentieth century organ
transplantation-have evoked concerns about the use of body parts
without consent; the psychological, social and religious impact of
deconstructing and undermining the integrity of the body; and,
especially, the potential exploitation of the individuals who serve as
the sources of organs and tissues. Physicians and scientists have been
accused of profiteering, insensitivity to the emotions of patients or
family members, and secrecy about unseemly practices as they have
sought out cadavers and body parts.
Recent disputes-over the taking of body tissue,5 the genetic
testing of previously-collected samples,6 the development of products
* Dorothy Nelkin is University Professor, New York University. Lori B. Andrews is
Professor of Law, Chicago-Kent College of Law and Director, Institute for Science, Law and
Technology, Illinois Institute of Technology. We acknowledge the support of the National
Science Foundation EVS program, grant number SBR-9710345.
1. See Interview with Helena Paul, Gaia Foundation, in London (June 1997).
2. See generally Moore v. Regents of the Univ. of Cal., 793 P.2d 479 (Cal. 1990), cert.
denied, 499 U.S. 936 (1991).
3. See generally Susan Essoyan, Two Marines Challenge Pentagon Order to Give DNA
Samples, L.A. TIMES, Dec. 27, 1995, at A5, A5.
4. See generally Ellen Wright Clayton et al., Informed Consent for Genetic Research on
Stored Tissue Samples, 274 JAMA 1786 (1995).
5. See generally, Mayfield v. Dalton, 109 F.3d 1423 (9th Cir. 1997).
6. See, e.g., Clayton et al.. supra note 4. at 1786. 1791. See generally Norman-Bloodsaw v.
Lawrence Berkeley Lab., 135 F.3d 1260 (9th Cir. 1998).
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made of body tissue,' the patentability of human genes8 and the
distribution of tissue'-raise important questions about the social and
legal status of the body. This symposium explores what the body
means to individuals, social groups, researchers and biotechnology
companies. It reveals a common practice of taking people's tissues
without their consent and documents the ways in which the law
attempts to infuse social meaning into decisions about the use of body
tissue. Increasingly, judges are being asked to mediate conflicts
involving body tissue. By bringing together perspectives on the
personal, religious and political significance of the body from the
vantage points of anthropology, political science, history, sociology
and ethics, we hope to help inform legal decisions about body tissue.
I. THE GROWTH OF INTEREST IN HUMAN TISSUE
Human tissue has always provided clues to health status. But the
body in the biotechnology age is speaking in new ways. Scientists
daily report their discoveries of genes for traits and disorders ranging
from homosexuality to manic depression, from colon cancer to
shyness, from Alzheimer's disease to a tendency to take risks. 0
Tissue such as hair, blood or saliva, when subject to DNA analysis,
can reveal intimate and detailed information about a person. Genetic
testing can indicate not only an individual's future health-
information that may open beneficial therapeutic or remedial
options-but also the possibility of employment or insurance
discrimination. 1 And, according to recent scientific claims, human
tissue can reveal information about behavioral traits, 12 race 3 or sexual
preference."4
7. See generally, e.g., Moore, 793 P.2d 479.
8. See generally, e.g., Rebecca S. Eisenberg, Patenting the Human Genome, 39 EMORY L.J.
721 (1990).
9. See, e.g., Pete Mitchell, European Researchers Condemn US Firm's Cord-Blood-Storage
Patent, 349 LANCET 1232, 1232 (1997).
10. See generally DOROTHY NELKIN & M. SUSAN LINDEE, THE DNA MYSTIQUE: THE
GENE AS A CULTURAL ICON (1995).
11. See DOROTHY NELKIN & LAURENCE TANCREDI, DANGEROUS DIAGNOSTICS: THE
SOCIAL POWER OF BIOLOGICAL INFORMATION 4,7 (1989). See generally NEIL A. HOLTZMAN,
PROCEED WITH CAUTION: PREDICTING GENETIC RISKS IN THE RECOMBINANT DNA ERA
(1989).
12. See Katrina Kelner & John Benditt, Genes and Behavior, 264 SCIENCE 1685, 1685
(1994).
13. See Gail Vines, Genes in Black and White, NEW SCIENTIST, July 8, 1995, at 34, 34.
14. See generally DEAN HAMER & PETER COPELAND, THE SCIENCE OF DESIRE: THE
SEARCH FOR THE GAY GENE AND THE BIOLOGY OF BEHAVIOR (1994).
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Beyond its value as a source of information, human tissue has
also become a source of raw material for products such as cell lines
and diagnostic tests. The market for skin, blood, placenta, gametes,
biopsied tissue and genetic material is expanding,15 driven in part by
commercial incentives fostered by legal developments in the 1980s. A
1980 U.S. federal law allowed universities and nonprofit institutions
to apply for patents on government-supported projects and provided
tax-incentives to companies investing in academic research. 16
Another law encouraged government researchers to enter into joint
ventures with for-profit companies. 7 At the same time, a landmark
U.S. Supreme Court decision in 1980 granted a patent on a life
form-a bacteria-setting the stage for the patenting of human
genes.18
As John Murray notes in this symposium, patents have now been
filed on more than 500,000 partial gene sequences and over 1500
patents have been granted for complete genes. Moreover, there are
multiple patents affecting particular single genes.1 9 Numerous groups
have patented variants of the breast cancer gene, and patent
applications are pending for additional mutations.20 This practice
raises concerns among some commentators who fear that too many
patents related to a single gene may actually impede useful research
since it will be difficult (and costly) for a researcher to gain licenses
from each patent holder.21 Murray examines the arguments for and
against patenting human genes.
Political scientist Sheldon Krimsky looks at the ways in which
patenting is influencing how researchers view each other and the
institutions within which they work.22 He documents the growing
commercial interests of scientists involved in the biotechnology
business,23 reviewing the history of industry-university liaisons and
the legislative basis of the rapid commercialization of molecular
15. See generally ANDREW KIMBRELL, THE HUMAN BODY SHOP: THE ENGINEERING AND
MARKETING OF LIFE (1993).
16. See generally 15 U.S.C. §§ 3701-3717 (1994 & Supp. III 1997).
17. See id. § 287n.
18. See Diamond v. Chakrabarty, 447 U.S. 303 (1980).
19. See John Murray, Note, Owning Genes: Disputes Involving DNA Sequence Patents, 75
CHI.-KENT L. REV. 231, 233-35 (1999).
20. See id.
21. See id. at 254.
22. Sheldon Krimsky, The Profit of Scientific Discovery and Its Normative Implications. 75
CHI.-KENT L. REv. 15, 28-35 (1999).
23. Id. at 27-28.
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genetics. 21 Krimsky looks critically at the consequences of scientists
becoming a part of the commercial sector with financial as well as
professional stakes in their research.2 5 He questions whether such
changes, eroding the normative basis of scientific research, will in the
long run yield a greater public benefit.26
As commercial interest in body tissue increases (and is
sanctioned through patent law), the social meaning of the body is
sometimes ignored. Yet personal and social views of the body serve
important functions for individuals and their communities. A
person's control over what is done to his or her body-or its parts-is
important to the individual's psychological development and well-
being. It is a means to establish identity and convey values to others.
Body tissue also has social importance beyond the individual. 27 Social
concepts of the body establish community identification, encourage
socially-responsible behaviors and set acceptable priorities for group
activities.
Developmental psychologists have written a great deal about the
formation of body image. Reviewing this complex literature,
psychologist Daniel Stern found a consistent theme-the critical
importance of coherence and bodily integrity to a person's
development and sense of self.28 To be healthy psychologically, an
individual needs to experience self-agency (the ability to control what
is done to one's body) and self-coherence (the ability to maintain the
body as a nonfragmented, integrated whole).
Because the body is a means to express personal values, some
people want to place limits on the use of their body parts. Some men
who donate sperm only want it used by married couples rather than
single women. 29 Some women will serve as a surrogate mother for
women with infertility problems but not for those who want to avoid
pregnancy for career reasons. 0 During the Nazi occupation of the
24. Id. at 18-22-
25. Id.
26. See id. at 39.
27. Cf. MARY DOUGLAS, PURITY AND DANGER: AN ANALYSIS OF THE CONCEPTS OF
POLLUTION AND TABOO (reprinted 1989) (1966) (discussing the relationship between rituals of
purity and cleansing and a sense of being or "unity in experience").
28. DANIEL N. STERN, THE INTERPERSONAL WORLD OF THE INFANT: A VIEW FROM
PSYCHOANALYSIS AND DEVELOPMENTAL PSYCHOLOGY (1985).
29. See generally Lori Andrews & Dorothy Nelkin, Whose Body Is It Anyway? Disputes
over Body Tissue in a Biotechnology Age, 35 LANCET 53 (1998).
30. See generally LORI ANDREWS, BETWEEN STRANGERS: SURROGATE MOTHERS,
EXPECTANT FATHERS, AND BRAVE NEW BABIES (1989).
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Netherlands, many citizens, as a form of social protest, refused to
participate in blood transfusions for Nazi soldiers.31 Some African-
American women, recalling past research abuses, refuse to allow
amniotic tissue to be collected for prenatal diagnosis out of concern
about the other uses that could be made of this tissue.32 Other people
object to the use of their tissue in the commercialized setting of
biotechnology firms. 3  John C. Mayfield and Joseph Vlacovsky, U.S.
Marines, refused to provide DNA to the military for its mandatory
DNA testing program (intended as a way to identify bodies killed in
war), and were court-martialed for noncompliance. 34  One of their
reasons for refusal was the "possible abuse of the information
contained in their DNA-from job or health insurance discrimination
on the basis of genetic traits to use of their samples without their
consent by medical researchers or the FBI. '3 Decisions people make
about the body and its parts convey important messages about their
individual identities, personal values, and political interests.
In this volume, Deborah Pergament explores, historically and
cross culturally, the complex social meanings of a specific body
tissue-hair.16 She suggests that just because hair is a regenerable
body part does not mean it has no social or individual importance. 37
Hair has importance for human dignity, for group identification, and
for status. Rituals, styles, and artifacts involving human hair suggest
its social meaning. The importance of hair as a cultural object arises
in the context of disputes over its commercialization and over the use
of hair for purposes of social control. Pergament examines how
courts often ignore the personal and social meaning of hair in cases
dealing with restrictions on hair appearance in schools, workplaces,
prisons, and the military.38 The social meaning of hair is an issue
31. See Dorothy Nelkin, Cultural Perspectives on Blood, in BLOOD FEUDS: AIDS, BLOOD,
AND THE POLITICS OF MEDICAL DISASTER 273, 278 (Eric A. Feldman & Ronald Bayer eds.,
1999).
32. See generally Rayna Rapp, Refusing Prenatal Diagnosis: The Meanings of Bioscience in
a Multicultural World, 23 SCI. TECH. & HUM. VALUES 45 (1998) (exploring the reasons that
women of different backgrounds reject prenatal diagnosis).
33. See generally Declan Butler, French Geneticists Split over Terms of Commercial Use of
DNA Bank, 368 NATURE 175 (1994).
34. See Mayfield v. Dalton, 901 F. Supp. 300, 302 (D. Haw. 1995), vacated, 109 F.3d 1423
(9th Cir. 1997).
35. Susan Essoyan, Two Marines Challenge Pentagon Order to Give DNA Samples, L.A.
TIMES, Dec. 27, 1995, at A5.
36. Deborah Pergament, It's Not Just Hair: Historical and Cultural Considerations for an
Emerging Technology, 75 CHI.-KENT L. REV. 41, 41-42 (1999).
37. See id. at 43-44.
38. Id. at 52-58.
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today as courts are increasingly involved in cases where hair analysis
is used to identify potential criminal offenders and discover drug
use.39
DNA analysis of body tissue is a means of social control in the
arena of law enforcement. The FBI and police are building DNA
databases by widely collecting blood and tissue samples from
individuals that can be used to match DNA found at crime scenes.4 1
Bioethicist Eric Juengst reviews debates over how DNA data is
collected, focussing in particular on the use of racial groups as
reference categories to assess DNA matches. 41 Using socially-defined
categories has implications for both personal privacy and the well
being of racial groups. Juengst points out that unlike traditional
fingerprinting, DNA "fingerprinting" can reveal a person's health
status and other sensitive information.42 And he shows how racial
categorization through DNA can lead to further stigmatization.43
Emphasizing the dangers of using DNA identification to categorize
people racially, he argues that population groups should not be used
as reference classes.44
Beyond the individual, body tissue has significant social meaning.
In some Third World societies, blood, hair and placenta are important
in social rituals, defining community identification and reinforcing the
values and rules that govern accepted behavior.45  But even in
contemporary Western societies, the treatment of body parts can
define community and reinforce social values. People signal their
identification with their community by the way they display and
manipulate their body-from the distinctive hair styles of African
Americans or Orthodox Jews to the symbols tattooed on the arms of
the Aryan Brotherhood. Sensitive questions emerge when genetic
analysis of body tissue is used to reveal community identity. Through
tissue analysis, a person may (whether that person wishes to or not)
be identified according to particular genetic criteria as a member of a
39. See id. at 57-58.
40. See Eric T. Juengst, I-DNA-fication, Personal Privacy, and Social Justice, 75 CHI.-KENT
L. REv. 61, 61 (1999).
41. Id. at. 63-64.
42. Id. at 64.
43. See id. at 75-77.
44. See id. at 77.
45. See generally VICTOR TURNER, THE FOREST OF SYMBOLS: ASPECTS OF NDEMBU
RITUAL (1967) (exploring various aspects of the ritual system of the Ndembu people); Rodney
Needham, Blood, Thunder and Mockery of Animals, 14 SOCIOLOGUS 136 (1964) (exploring a
blood sacrifice ritual that was common among certain tribes).
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certain family, a certain race, a certain culture or a certain sex. 46
Some patients do not want their tissue used (even without their
names attached) for research on race and I.Q., race and crime, or
gender and mathematical ability.47 They fear that the findings of such
research could label and stigmatize their group.48
Norms that guide the disposition of body tissue reflect
community ideals. Thus, in particular social contexts, the priorities
for body use are not always the same as those advocated by scientists
or commercial interests. Giving blood and body tissue rather than
selling it, for example, is a way of encouraging altruism and affirming
social connectedness by linking donors to strangers through donations
in the interest of the public good. But these community ideals have
clashed with commercial interests in the development of private cord
blood banks and the patenting of the cord blood stem cell extraction
technique. Those who believe that cord blood should be a public
resource, freely available to those in need of therapy, have challenged
companies that see patenting and privatization as essential for
investment in research.49
The wide range of social meanings placed upon the body-in
defining community, reinforcing acceptable behavior and establishing
priorities-have converged in disputes surrounding the Human
Genome Diversity Project (the "HGDP"). Anthropologist Margaret
Lock analyzes the objectives of the HGDP: to immortalize cell lines
from indigenous peoples worldwide and, in particular, from the
isolated populations who have unique genetic profiles due to their
history of isolation and intermarriage.10 Scientists claim that the cell
lines of "genetically pure" populations are of special scientific interest
as a means to reconstruct migratory history and disclose human
genetic variation." But this plan to collect their cell lines has been
politically and ethically controversial. Lock describes the major
problems confronting the HGDP: the science itself (based on the
notion of pure populations) is questionable; the claims that the
46. See Andrews & Nelkin, supra note 29, at 54 (portions of this article reproduced in this
paragraph in their entirety with permission of the authors).
47. See id.
48. See id.
49. See George J. Annas, Waste and Longing-The Legal Status of Placental-Blood
Banking, 340 NEW ENG. J. MED. 1521, 1521-24 (1999). See generally Jeremy Sugarman et al.,
Ethical Issues in Umbilical Cord Blood Banking, 278 JAMA 938 (1997).
50. Margaret Lock, Genetic Diversity and the Politics of Difference, 75 CHI.-KENT L. REV.
83, 83, 91-93 (1999).
51. Id. at 94-96.
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research would benefit the community providing the DNA are often
false; the reductionist approach ignores the social assumptions
underlying the scientific claims and the ways in which scientific
findings about human differences can be used for political agendas;
and the project has made little effort to involve the individuals who
are to provide the tissue samples for extracting their DNA.52 The
increasingly commercial context of the research exacerbates these
problems. In this context, Lock contrasts scientific claims with the
responses of indigenous peoples who are concerned about the
problems of regulating the research, the ownership of genetic
material, and the potential for discrimination, stigmatization and
eugenics on the basis of information about their particular genetic
profiles.53
Information from human tissue can be used for political
purposes, such as denying an indigenous person's claims to land if his
genetic profile does not match that of the appropriate ancestor group.
But even well-intentioned medical uses of body tissue may have a
larger political significance as historian M. Susan Lindee
demonstrates in this volume. Lindee investigates a particular episode
in the medical collection of human body tissue-the political history
of the collection of babies' blood for PKU (phenylketonuria) testing. 54
She shows how the system of organization, manipulation and control
of bodily materials, served prevailing political interests in
constructing PKU as a compelling public health problem.55 This
disease, in effect, conformed to a network of political interests in the
social management of genetic disease. The development of what
appeared to be a diagnostic test that offered the prospect of
intervention, quickly led to legislation mandating the test.5 6 Even
though many scientific questions remained, these mandates
effectively closed off other options.
II. INTEGRATING CULTURAL MEANING INTO POLICY
Scientists seeking unimpeded access to human tissue argue that
restraints on their ability to gain access to, manipulate and
52. Id. at 96-99, 100-101,109-110.
53. Id. at 84-85.
54. M. Susan Lindee, Babies' Blood: Fragmentation, Redemption and Phenylketonuria, 75
CHI.-KENT L. REv.113, 114-16 (1999).
55. See id. at 117-21.
56. See id. at 124-26.
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commercialize tissue obstruct the progress of research and deprive
society of useful medical benefits. But that argument is wearing thin
with growing awareness of the downside of certain genetic advances.
Genetic diagnosis of late-onset disorders have meant that many
currently healthy people live under the Damocles' sword of knowing
they are at enhanced risk for later illnesses such as breast cancer or
Alzheimer's disease.57  Current "treatments" such as prophylactic
oophorectomy for women who learn they are at higher than average
genetic risk for ovarian cancer may be risky, disruptive (causing the
woman to lose her ability to have children), and unnecessary (since
the majority of the women with the genetic mutation do not develop
ovarian cancer).58 Such "treatments" may also be ineffective because
some women still develop cancer in the remaining tissue.59
Moreover, claims about the benefits gained by unrestricted
access to patient tissue have been exaggerated. A federally-
appointed committee investigating gene therapy found that even
though 567 Americans had undergone gene therapy in approximately
one hundred different experiments, "there is still little or no evidence
of therapeutic benefit [of gene therapy] in patients, or even in animal
models." 6 The panel condemned most of the efforts as pure hype
and expressed concern that in the rush to undertake gene therapy, the
development of other easier-to-achieve conventional treatments for
the same diseases was likely to be ignored.61 There appears to be a
growing backlash against "genetic hucksterism." 62
Public attitudes also reflect concerns about the fragmentation of
the body that is implied by genetic medicine. Molecular biologist
Leroy Hood, for example, predicts a future in which "[y]our entire
genome and medical history will be on a credit card .... Physicians
will really then have to look at humans as complex systems analysis"
and medicine will be "manned by mathematicians. ' 63 However,
57. See Ruth Hubbard & R.C. Lewontin, Pitfalls of Genetic Testing, 334 NEW ENG. J. MED.
1192, 1192-93 (1996).
58. See Andrew Berchuck et al., Genetic Susceptibility Testing and Prophylactic
Oopherectomy, 82 EUR. J. OBSTETRIC & GYNECOLOGICAL REPROD. BIOLOGY 159, 160 (1999).
59. See id. at 162.
60. Laurie Garrett, The Dots are Almost Connected .... Then What?: Mapping the Human
Genetic Code, L.A. TIMES MAG., Mar. 3, 1996, at 22.
61. Report and Recommendations of the Panel to Assess the NIH Investment in Research on
Gene Therapy (Stuart H. Orkin & Arno G. Motulsky, co-chairs, Dec. 7, 1995)
<http://www.nih.gov/od/orda/panelrep.htm>.
62. Keay Davidson, DNA: High Hopes or Just Hype?, Hous. CHRON., Sept. 29, 1996, at 2,
2.
63. Garrett, supra note 60, at 48-49.
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delivering medicine in this way runs counter to people's growing
interest in a more holistic view of medicine and increasing desires for
treatments that view the patients as a whole rather than focussing on
particular small parts.64
Tensions between the potential contribution of unfettered
research to scientific and medical progress and social concerns have
been reflected in legal and policy decisions. A decade ago, in Moore
v. Regents of the University of California,65 a patient sued his physician
and a biotechnology company alleging they had used his biopsied
tissue without his consent and transformed it into a patented
commercial cell line. 66 The court sided with the interests of the
defendants. The court reasoned that giving the patient a property
right to his tissue would impede progress and "destroy the economic
incentive to conduct important medical research. '67
However, in more recent decisions, the federal government,
professional societies, institutional review boards, and courts have
considered values beyond economic incentives and scientific progress.
Some institutional review boards, for example, have integrated
cultural values into the protocols for the retrieval and use of human
tissue, giving patients increased rights to control the uses made of
their body material. Some physicians have claimed that they should
not have to obtain Institutional Review Board approval and the
informed consent of patients for undertaking genetics research
because it only involved a "simple blood test." But the Office for
Protection from Research Risks of the U.S. National Institutes of
Health underscored why consent and external review are necessary:
"Genetic studies that generate information about subjects' personal
health risk can provoke anxiety and confusion, damage familial
relationships, and compromise the subjects' insurability and
employment opportunities. '6
When researchers sought to analyze previously-collected tissue
samples at the Centers for Disease Control, an advisory group
pointed out that "retaining tissue samples or immortalizing cell lines
64. See generally Lori B. Andrews, The Shadow Health Care System: Regulation of
Alternative Health Care Providers, 32 HouS. L. REV. 1273 (1996).
65. 793 P.2d 479 (Cal. 1990).
66. Id. at 480-82.
67. Id. at 495.
68. OPRR, PROTECTING HUMAN RESEARCH SUBJECTS: INSTITUTIONAL REVIEW BOARD
GUIDEBOOK § 5, at 43 (1993).
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may violate cultural or religious beliefs. '69 Guidelines issued by the
American College of Medical Genetics require that patients be asked
for consent before research is done on their tissue samples and that
patients have an option to have their samples withdrawn or destroyed
at any time.7°
Even in the Moore case, the California Supreme Court held that
the physician violated his fiduciary duty by not telling the patient in
advance of surgery that he had a commercial interest in the tissue: "a
physician who treats a patient in whom he also has a research interest
has potentially conflicting loyalties."71 The court expressed concern
that "physician[s] ... may be tempted to order a scientifically useful
procedure or test that offers marginal, or no, benefits to the
patient."72
And in a dispute between a couple and their physician over
whether the couple could take their embryo to another facility for
implantation, the court held that the embryo was the couple's
property even though housed in the physician's lab.73 The physician
was merely the custodian of their tissue.74
Courts have also recognized the psychological impact on families
of how body parts of a deceased relative are treated. In one case, the
U.S. Army-without notice to the family and without their consent-
performed an autopsy on the body of a serviceman, removed certain
body parts to be retained "indefinitely" and then cremated the rest of
the body.75 The court held that, even though the autopsy itself was
not actionable, the parents could recover emotional distress damages
for the removal of body parts and cremation.7 6 The parents of the
serviceman were entitled to $210,000 in damages because the United
States' handling of the body violated the Jewish plaintiffs' religious
beliefs.77
Cultural norms, too, are beginning to influence the treatment of
body tissue. The North American Advisory Group to the Human
69. Clayton et al., supra note 4, at 1788.
70. See American College of Medical Genetics Statement: Statement on Storage and Use of
Genetic Materials, 57 AM. J. HUM. GENETICS 1499, 1499-1500 (1995).
71. 793 P.2d at 484.
72. Id.
73. See York v. Jones, 717 F. Supp. 421, 425-27 (E.D. Va. 1989).
74. See id. at 427.
75. See Kohn v. United States, 591 F. Supp. 568, 570, 573 (E.D.N.Y. 1984), affd, 760 F.2d
253 (2d Cir. 1985).
76. See id. at 572-74.
77. See id. at 575.
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Genome Diversity Project has stressed the importance of sensitivity
to community values in the collection of tissue from indigenous
groups.7 8 They would require that the current process be handled in a
culturally appropriate way-including the need for consent from a
representative or the leader of the group or tribe, not just from the
individuals being sampled. 79
This trend is part of a larger legal movement around the world
that is giving increased respect to the emotional impact of violations
of autonomy. As described by Kathy Laster and Pat O'Malley, courts
throughout the world are beginning to reconsider the motivations,
passions and particular circumstances of individuals. 80 Applied to the
taking of human tissue, this trend recognizes the benefits that can
accrue to individuals and society from respecting the cultural
meanings of the body.
78. See Patricia Kahn, Genetic Diversity Project Tries Again, 266 SCIENCE 720, 720-22
(1994).
79. See id.
80. See Kathy Laster & Pat O'Malley, Sensitive New-Age Laws: The Reassertion of
Emotionality in Law, 24 INT'L J. Soc. L. 21, 24-31 (1996).
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